pSS patients exhibit biomarkers of B cell activation, including polyclonal hypergammaglobulinemia, elevated levels of free light chains, and autoantibodies such as rheumatoid factor (RF), anti-Ro/anti-Sjögren's syndrome A antigen (anti-SSA) antibodies, and anti-La/SSB antibodies. This evidence concerns the gene CALR and peeling skin syndrome.